Document Detail


Evaluation of glycopeptide use in nine French hospitals.
MedLine Citation:
PMID:  19959309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Adequate glycopeptide use is necessary to optimize efficacy and minimize adverse events and selection of drug resistant microorganisms. METHODS: We performed a multicenter prospective observational study of glycopeptides indications based on modified HICPAC criteria, and quality of prescription based on French consensus recommendations. We assessed the adequacy of indications, loading dose, maintenance dose, administration frequency, serum monitoring and its consequences. RESULTS: We evaluated 117 curative adult prescriptions from nine hospitals. Glycopeptide indications were adequate in 71% with either a clinical (55%) or microbiological justification (27%). The indication was more frequently adequate for vancomycin than for teicoplanin (77% vs. 60%, p=0.04). De-escalation therapy was performed in 48% of all documented infections and 78% of documented infections with betalactam susceptible strains. We observed high rates of correct maintenance dose (90%), administration frequency (88%), and serum monitoring (74%). Loading doses (43%), adequate serum monitoring timing (43%), correction of dose because of inadequate levels (32%) were less adequate. Overall, only three (3%) treatments were adequate for all evaluated items. CONCLUSION: Glycopeptide indications were adequate. However, the quality of prescription can be improved and should focus on loading doses and serum monitoring.
Authors:
S Alfandari; T Levent; D Descamps; S Hendricx; C Bonenfant; V Taines; C Cattoen; O Arimane; B Grandbastien
Related Documents :
8236359 - Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposi...
19112219 - The influence of maintenance quality of hemodialysis machines on hemodialysis efficiency.
12851659 - Influence of honey on the pharmacokinetics of phenytoin in healthy rabbits.
1889149 - Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
11493369 - Effects of paeoniae radix, a traditional chinese medicine, on the pharmacokinetics of p...
3395099 - Effect of cardiopulmonary bypass on vancomycin and netilmicin disposition.
15094269 - Comparison of first-line antiretroviral therapy with regimens including nevirapine, efa...
21797809 - Dna double-strand breaks induced by mammographic screening procedures in human mammary ...
10771039 - The novel kappa-opioid receptor agonist trk-820 has no affect on the development of ant...
Publication Detail:
Type:  Journal Article; Multicenter Study     Date:  2009-12-02
Journal Detail:
Title:  Médecine et maladies infectieuses     Volume:  40     ISSN:  1769-6690     ISO Abbreviation:  Med Mal Infect     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-09-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0311416     Medline TA:  Med Mal Infect     Country:  France    
Other Details:
Languages:  eng     Pagination:  232-7     Citation Subset:  IM    
Copyright Information:
Copyright 2009 Elsevier Masson SAS. All rights reserved.
Affiliation:
Service de réanimation et maladies infectieuses, centre hospitalier, 155, rue du Président Coty, 59208 Tourcoing, France. alfandari.s@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Bacterial Agents* / administration & dosage,  blood,  therapeutic use
Bacterial Infections / drug therapy*
Cross Infection / drug therapy*
Dose-Response Relationship, Drug
Drug Monitoring
Drug Prescriptions / statistics & numerical data*
Drug Resistance, Microbial
Drug Utilization Review*
France
Guideline Adherence
Hospitals / statistics & numerical data*
Hospitals, Private / statistics & numerical data
Hospitals, Public / statistics & numerical data
Hospitals, University / statistics & numerical data
Humans
Infusions, Intravenous
Prospective Studies
Teicoplanin* / administration & dosage,  blood,  therapeutic use
Vancomycin* / administration & dosage,  blood,  therapeutic use
Vancomycin Resistance
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 1404-90-6/Vancomycin; 61036-62-2/Teicoplanin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Septic osteomyelitis of the hip after Fusobacterium necrophorum pharyngitis].
Next Document:  Cutting-balloon angioplasty of resistant ureteral stenosis as bridge to stent insertion.